
1. clin cancer res. 2008 may 1;14(9):2813-23. doi: 10.1158/1078-0432.ccr-07-1528.

treatment radioresistant stem-like esophageal cancer cells apoptotic
gene-armed, telomerase-specific oncolytic adenovirus.

zhang x(1), komaki r, wang l, fang b, chang jy.

author information: 
(1)department radiation oncology, university texas m. d. anderson
cancer center, houston, texas 77030, usa.

purpose: radioresistance may caused cancer stem cells (csc). cscs
require telomerase proliferate, telomerase-specific oncolytic adenoviral
vector carrying apoptotic tumor necrosis factor-related apoptosis-inducing ligand
and e1a gene (ad/trail-e1) may preferentially target cscs.
experimental design: established two pairs parental radioresistant (r) 
esophageal carcinoma cell lines (seg-1, seg-1r te-2, te-2r) fractionated
irradiation. stem cell markers measured western blotting flow
cytometry. serial sorting used enrich stem-like side population cells.
telomerase activity, transgene expression, antitumor activity, apoptosis
induction, viral replication determined vitro and/or vivo.
results: expression stem cell markers beta-catenin, oct3/4, beta(1)
integrin seg-1r cells 29.4%, 27.5%, 97.3%, respectively, compared with
4.8%, 14.9%, 45.3% seg-1 cells (p < 0.05). sp levels seg-1r te-2r
cells 14.6% 2.7%, respectively, compared 3.4% 0.3% seg-1 and
te-2 cells. serial sorting seg-1r sp cells showed enrichment sp cells. 
telomerase activities seg-1r, seg-1r sp, te-2r cells significantly
higher seg-1, seg-1r non-sp, te-2 cells, respectively (p < 0.05).
seg-1r te-2r cells sensitive ad/trail-e1 parental cells.
increased coxsackie-adenovirus receptor elevated transgene expressions were
found radioresistant cells. ad/trail-e1 resulted significant tumor
growth suppression longer survival seg-1r-bearing mice (p < 0.05) 
significant toxicity.
conclusion: radioresistant cells established fractionated irradiation display 
csc-like cell properties. ad/trail-e1 preferentially targets radioresistant
csc-like cells.

doi: 10.1158/1078-0432.ccr-07-1528 
pmcid: pmc2387204
pmid: 18451249  [indexed medline]

